Literature DB >> 7759113

COL5A1: fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II.

D S Greenspan1, H Northrup, K S Au, K A McAllister, C A Francomano, R J Wenstrup, D A Marchuk, D J Kwiatkowski.   

Abstract

COL5A1, the gene for the alpha 1 chain of type V collagen, has been considered a candidate gene for certain diseases based on chromosomal location and/or disease phenotype. We have employed 3'-untranslated region RFLPs to exclude COL5A1 as a candidate gene in families with tuberous sclerosis 1, Ehlers-Danlos syndrome type II, and nail-patella syndrome. In addition, we describe a polymorphic simple sequence repeat (SSR) within a COL5A1 intron. This SSR is used to exclude COL5A1 as a candidate gene in hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) and to add COL5A1 to the existing map of "index" markers of chromosome 9 by evaluation of the COL5A1 locus on the CEPH 40-family reference pedigree set. This genetic mapping places COL5A1 between markers D9S66 and D9S67.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759113     DOI: 10.1016/0888-7543(95)80021-d

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II).

Authors:  U Schwarze; M Atkinson; G G Hoffman; D S Greenspan; P H Byers
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

Review 2.  The Ehlers-Danlos syndrome: on beyond collagens.

Authors:  J R Mao; J Bristow
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.

Authors:  A De Paepe; L Nuytinck; I Hausser; I Anton-Lamprecht; J M Naeyaert
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 4.  Ehlers-Danlos syndrome has varied molecular mechanisms.

Authors:  F M Pope; N P Burrows
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

5.  COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS.

Authors:  R J Wenstrup; J B Florer; M C Willing; C Giunta; B Steinmann; F Young; M Susic; W G Cole
Journal:  Am J Hum Genet       Date:  2000-04-24       Impact factor: 11.025

6.  An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.

Authors:  A C Nicholls; J E Oliver; S McCarron; J B Harrison; D S Greenspan; F M Pope
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

7.  A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.

Authors:  N P Burrows; A C Nicholls; A J Richards; C Luccarini; J B Harrison; J R Yates; F M Pope
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

8.  A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II.

Authors:  A J Richards; S Martin; A C Nicholls; J B Harrison; F M Pope; N P Burrows
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

9.  Genomic analysis of 21 patients with corneal neuralgia after refractive surgery.

Authors:  Jun-Hui Yuan; Betsy R Schulman; Philip R Effraim; Dib-Hajj Sulayman; Deborah S Jacobs; Stephen G Waxman
Journal:  Pain Rep       Date:  2020-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.